Startup · $4m raised
Sydney, NSW
Every investor coverage indicates participated in a round JumpStart Fertility raised.
| Investor | Rounds | Invested |
|---|---|---|
| Proto Axiom | Unnamed stage | $4,000,000 |
| VU Venture Partners | Unnamed stage | - |
Companies JumpStart Fertility acquired or merged with, per published coverage. Buying a company is not investing in one: nothing here counts in the deals column.
| Name | Role | Sources |
|---|---|---|
| Dr Lindsay Wu | Lead Researcher | Forbes Australia |
Stories naming JumpStart Fertility. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Proto Axiom has put $4 million into Sydney IVF biotech JumpStart Fertility, a UNSW spin-out, to pay for human trials of a treatment aimed at age-related fertility decline.